Trials / Completed
CompletedNCT02890966
Multiple Dose Study of SHR4640 in Healthy Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of SHR4640 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The objective of the study is to assess the tolerance, pharmacokinetic and pharmacodynamic properties of multiple dose adminstration of SHR4640 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR4640 | Day1\~Day7:oral administration |
| DRUG | placebo | Day1\~Day7:oral administration |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2017-02-01
- Completion
- 2017-03-01
- First posted
- 2016-09-07
- Last updated
- 2017-03-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02890966. Inclusion in this directory is not an endorsement.